-
Whole Genome Covid-19 Sequencing Study Proves WGS Ready for Therapeutic Development
Bio-IT World | Last month an international team of researchers published whole genome sequencing results comparing thousands of individuals with critical Covid-19 to a control group, discovering and replicating 23 independent variants that significantly predispose an individual to critical Covid-19. The exercise yielded fruit for very large scale whole genome sequencing projects as well.
Apr 14, 2022
-
Automated Data Cleaning and AI Pipelines for Increased Enterprise-Wide Adoption
Bio-IT World | The current data-rich era comes with a tremendous number of caveats. Large quantities of data are not necessarily high quality. Quality, in this case, can be used to describe the ease with which a user can obtain useful insights. Here we look at practices within a business that can maintain data integrity to prepare it for automated AI pipelines among other uses.
Apr 13, 2022
-
The Right Questions: Bayer’s Approach to Data Challenges and COVID-19
Bio-IT World | The way Jeanne Kehren sees it, pharma either has data graveyards, or “We are building data lakes without thinking about getting a boat.” Neither option advances the life sciences mission. As SVP and CIO at Bayer, Kehren is working toward a new vision of how pharma uses data, what it means to ask the right question, and how the healthcare industry as a whole can serve patients. COVID-19, she said, has been both a magnifier of some of our challenges and an opportunity.
Apr 12, 2022
-
Bio-IT World Names 2022 Innovative Practices Awards Winners
Bio-IT World | Bio-IT World today announced the 2022 Innovative Practices Awards winners. Four grand prize awards were granted to AstraZeneca, Guardant Health with IQVIA, Merck KGaA, Darmstadt, Germany, with Genedata, and Quantum Leap Healthcare Collaborative / University of California San Francisco with OpenClinica. The awards ceremony will be held during the plenary program on Tuesday, May 3, at the 2022 Bio-IT World Conference & Expo in Boston.
Apr 11, 2022


